Zomedica Corp.
ZOMDF
$0.05
$0.00142.88%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 27.29M | 26.73M | 26.08M | 25.97M | 25.19M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 27.29M | 26.73M | 26.08M | 25.97M | 25.19M |
| Cost of Revenue | 8.20M | 8.12M | 8.16M | 8.37M | 7.87M |
| Gross Profit | 19.09M | 18.61M | 17.91M | 17.60M | 17.32M |
| SG&A Expenses | 46.85M | 48.65M | 47.44M | 45.47M | 43.17M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 62.31M | 64.99M | 62.84M | 60.43M | 56.78M |
| Operating Income | -35.03M | -38.26M | -36.77M | -34.47M | -31.59M |
| Income Before Tax | -47.54M | -62.07M | -57.76M | -39.01M | -35.86M |
| Income Tax Expenses | -557.00K | 123.00K | -1.77M | -1.70M | -1.33M |
| Earnings from Continuing Operations | -46.98 | -62.19 | -55.99 | -37.31 | -34.53 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -46.98M | -62.19M | -55.99M | -37.31M | -34.53M |
| EBIT | -35.03M | -38.26M | -36.77M | -34.47M | -31.59M |
| EBITDA | -27.04M | -30.45M | -29.39M | -27.60M | -25.29M |
| EPS Basic | -0.05 | -0.06 | -0.06 | -0.04 | -0.04 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Diluted | -0.06 | -0.06 | -0.06 | -0.04 | -0.04 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 3.92B | 3.92B | 3.92B | 3.92B | 3.92B |
| Average Diluted Shares Outstanding | 3.92B | 3.92B | 3.92B | 3.92B | 3.92B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |